Sbi Securities Co., Ltd. Novo Cure LTD Transaction History
Sbi Securities Co., Ltd.
- $3.25 Trillion
- Q4 2024
A detailed history of Sbi Securities Co., Ltd. transactions in Novo Cure LTD stock. As of the latest transaction made, Sbi Securities Co., Ltd. holds 2,341 shares of NVCR stock, worth $56,605. This represents 0.0% of its overall portfolio holdings.
Number of Shares
2,341Holding current value
$56,605% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding NVCR
# of Institutions
266Shares Held
76.7MCall Options Held
1.17MPut Options Held
318K-
Black Rock Inc. New York, NY12.1MShares$293 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA11.8MShares$286 Million0.0% of portfolio
-
Capital International Investors Los Angeles, CA7.92MShares$192 Million0.02% of portfolio
-
Capital World Investors Los Angeles, CA4.31MShares$104 Million0.01% of portfolio
-
Nordwand Advisors, LLC Radnor, PA3.03MShares$73.3 Million12.67% of portfolio
About NovoCure Ltd
- Ticker NVCR
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Instruments & Supplies
- Shares Outstandng 104,950,000
- Market Cap $2.54B
- Description
- NovoCure Limited, an oncology company, engages in the development, manufacture, and commercialization of tumor treating fields (TTFields) devices for the treatment of solid tumor cancers in the United States, Europe, the Middle East, Africa, Japan, and Greater China. Its TTFields devices include Optune for the treatment of glioblastoma; and Optu...